Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease
JAMA Intern Med. 2026 Feb 23. doi: 10.1001/jamainternmed.2025.8087. Online ahead of print.ABSTRACTIMPORTANCE: Dual bronchodilator therapy with a long-acting muscarinic antagonist (LAMA) and a long-acting β2-agonist (LABA) is recommended for most patients with symptomatic chronic obstructive pulmonar

